We've found
2,371 Crohns Disease
clinical trials
We've found
2,371 Crohns Disease
clinical trials
Crohn Disease Clinical Trial
Updated: 12/31/1969
Open-Label Extension and Safety Study for Patients With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
Open-Label Extension and Safety Study for Patients With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
Open-Label Extension and Safety Study for Patients With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
Open-Label Extension and Safety Study for Patients With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
Open-Label Extension and Safety Study for Patients With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
Triple Combination Therapy in High Risk Crohn's Disease (CD)
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
Triple Combination Therapy in High Risk Crohn's Disease (CD)
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
Triple Combination Therapy in High Risk Crohn's Disease (CD)
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
Triple Combination Therapy in High Risk Crohn's Disease (CD)
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
Safety and Efficacy Study of JNJ-64304500 in Participants With Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Gastroenterology Clinical Trial
Updated: 12/31/1969
Improving the Quality of Care for Adults With Inflammatory Bowel Disease
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Gastroenterology Clinical Trial
Updated: 12/31/1969
Improving the Quality of Care for Adults With Inflammatory Bowel Disease
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Gastroenterology Clinical Trial
Updated: 12/31/1969
Improving the Quality of Care for Adults With Inflammatory Bowel Disease
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
Safety and Efficacy Study of Oral Ferric Maltol Compared to Intravenous Iron To Treat Iron Deficiency Anaemia in IBD
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
Safety and Efficacy Study of Oral Ferric Maltol Compared to Intravenous Iron To Treat Iron Deficiency Anaemia in IBD
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
Safety and Efficacy Study of Oral Ferric Maltol Compared to Intravenous Iron To Treat Iron Deficiency Anaemia in IBD
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
Safety and Efficacy Study of Oral Ferric Maltol Compared to Intravenous Iron To Treat Iron Deficiency Anaemia in IBD
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Ulcerative Colitis and Crohn's Disease Clinical Trial
Updated: 12/31/1969
Entyvio (Vedolizumab) Long Term Safety Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Ulcerative Colitis and Crohn's Disease Clinical Trial
Updated: 12/31/1969
Entyvio (Vedolizumab) Long Term Safety Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Ulcerative Colitis and Crohn's Disease Clinical Trial
Updated: 12/31/1969
Entyvio (Vedolizumab) Long Term Safety Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn's Disease Clinical Trial
Updated: 12/31/1969
A Six Week Efficacy, Safety and Tolerability Study of V565 in Crohn's Disease
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn's Disease Clinical Trial
Updated: 12/31/1969
Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn's Disease Clinical Trial
Updated: 12/31/1969
Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn's Disease Clinical Trial
Updated: 12/31/1969
Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn's Disease Clinical Trial
Updated: 12/31/1969
Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn's Disease Clinical Trial
Updated: 12/31/1969
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn's Disease Clinical Trial
Updated: 12/31/1969
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn's Disease Clinical Trial
Updated: 12/31/1969
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Gastroenterology Clinical Trial
Updated: 12/31/1969
Vedolizumab Subcutaneous Long-Term Open-Label Extension Study
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Gastroenterology Clinical Trial
Updated: 12/31/1969
Vedolizumab Subcutaneous Long-Term Open-Label Extension Study
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Gastroenterology Clinical Trial
Updated: 12/31/1969
Vedolizumab Subcutaneous Long-Term Open-Label Extension Study
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Gastroenterology Clinical Trial
Updated: 12/31/1969
Personalized Research on Diet in Ulcerative Colitis and Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Gastroenterology Clinical Trial
Updated: 12/31/1969
A Safety Extension Study of SHP647 in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Gastroenterology Clinical Trial
Updated: 12/31/1969
A Safety Extension Study of SHP647 in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Gastroenterology Clinical Trial
Updated: 12/31/1969
A Safety Extension Study of SHP647 in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Gastroenterology Clinical Trial
Updated: 12/31/1969
A Safety Extension Study of SHP647 in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Gastroenterology Clinical Trial
Updated: 12/31/1969
A Safety Extension Study of SHP647 in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Gastroenterology Clinical Trial
Updated: 12/31/1969
A Safety Extension Study of SHP647 in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Gastroenterology Clinical Trial
Updated: 12/31/1969
A Safety Extension Study of SHP647 in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Gastroenterology Clinical Trial
Updated: 12/31/1969
A Safety Extension Study of SHP647 in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Gastroenterology Clinical Trial
Updated: 12/31/1969
A Safety Extension Study of SHP647 in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Gastroenterology Clinical Trial
Updated: 12/31/1969
A Safety Extension Study of SHP647 in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Gastroenterology Clinical Trial
Updated: 12/31/1969
A Safety Extension Study of SHP647 in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Gastroenterology Clinical Trial
Updated: 12/31/1969
A Safety Extension Study of SHP647 in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Gastroenterology Clinical Trial
Updated: 12/31/1969
A Trial of Yoga in Pediatric Inflammatory Bowel Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Fistulizing Crohn's Disease Clinical Trial
Updated: 12/31/1969
Efficacy and Safety of Filgotinib in the Treatment of Perianal Fistulizing Crohn's Disease
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Fistulizing Crohn's Disease Clinical Trial
Updated: 12/31/1969
Efficacy and Safety of Filgotinib in the Treatment of Perianal Fistulizing Crohn's Disease
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Fistulizing Crohn's Disease Clinical Trial
Updated: 12/31/1969
Efficacy and Safety of Filgotinib in the Treatment of Perianal Fistulizing Crohn's Disease
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn's Disease Clinical Trial
Updated: 12/31/1969
A Study to Assess the Efficacy and Safety of Risankizumab in Subjects With Moderately to Severely Active Crohn's Disease Who Failed Prior Biologic Treatment
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn's Disease Clinical Trial
Updated: 12/31/1969
A Study to Assess the Efficacy and Safety of Risankizumab in Subjects With Moderately to Severely Active Crohn's Disease Who Failed Prior Biologic Treatment
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn's Disease Clinical Trial
Updated: 12/31/1969
A Study to Assess the Efficacy and Safety of Risankizumab in Subjects With Moderately to Severely Active Crohn's Disease Who Failed Prior Biologic Treatment
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn's Disease Clinical Trial
Updated: 12/31/1969
A Study to Assess the Efficacy and Safety of Risankizumab in Subjects With Moderately to Severely Active Crohn's Disease Who Failed Prior Biologic Treatment
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn's Disease Clinical Trial
Updated: 12/31/1969
A Study to Assess the Efficacy and Safety of Risankizumab in Subjects With Moderately to Severely Active Crohn's Disease Who Failed Prior Biologic Treatment
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn's Disease Clinical Trial
Updated: 12/31/1969
A Study of the Efficacy and Safety of Risankizumab in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn's Disease Clinical Trial
Updated: 12/31/1969
A Study of the Efficacy and Safety of Risankizumab in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn's Disease Clinical Trial
Updated: 12/31/1969
A Study of the Efficacy and Safety of Risankizumab in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn's Disease Clinical Trial
Updated: 12/31/1969
A Study of the Efficacy and Safety of Risankizumab in Subjects With Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Gastroenterology Clinical Trial
Updated: 12/31/1969
A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel Disease
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Gastroenterology Clinical Trial
Updated: 12/31/1969
A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel Disease
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Gastroenterology Clinical Trial
Updated: 12/31/1969
A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel Disease
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Pediatric Crohn's Disease Clinical Trial
Updated: 12/31/1969
Low Dose Oral Methotrexate in Pediatric Crohn's Disease Patients Initiating Anti-Tumor Necrosis Factor (Anti-TNF) Therapy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn's Disease Clinical Trial
Updated: 12/31/1969
A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Biologic Therapy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn's Disease Clinical Trial
Updated: 12/31/1969
A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Biologic Therapy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn's Disease Clinical Trial
Updated: 12/31/1969
A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Biologic Therapy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn's Disease Clinical Trial
Updated: 12/31/1969
A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Biologic Therapy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn's Disease Clinical Trial
Updated: 12/31/1969
A Study of the Efficacy and Safety of Upadacitnib (ABT-494) in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Conventional Therapies But Have Not Failed Biologic Therapy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn's Disease Clinical Trial
Updated: 12/31/1969
A Study of the Efficacy and Safety of Upadacitnib (ABT-494) in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Conventional Therapies But Have Not Failed Biologic Therapy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn's Disease Clinical Trial
Updated: 12/31/1969
A Study of the Efficacy and Safety of Upadacitnib (ABT-494) in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Conventional Therapies But Have Not Failed Biologic Therapy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn's Disease Clinical Trial
Updated: 12/31/1969
A Study of the Efficacy and Safety of Upadacitnib (ABT-494) in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Conventional Therapies But Have Not Failed Biologic Therapy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn's Disease Clinical Trial
Updated: 12/31/1969
A Study of the Efficacy and Safety of Upadacitnib (ABT-494) in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Conventional Therapies But Have Not Failed Biologic Therapy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn's Disease Clinical Trial
Updated: 12/31/1969
A Study of the Efficacy and Safety of Risankizumab in Subjects With Crohn's Disease Who Responded to Induction Treatment in M16-006 or M15-991; or Completed M15-989
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn's Disease Clinical Trial
Updated: 12/31/1969
A Study of the Efficacy and Safety of Risankizumab in Subjects With Crohn's Disease Who Responded to Induction Treatment in M16-006 or M15-991; or Completed M15-989
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn's Disease Clinical Trial
Updated: 12/31/1969
A Study of the Efficacy and Safety of Risankizumab in Subjects With Crohn's Disease Who Responded to Induction Treatment in M16-006 or M15-991; or Completed M15-989
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn's Disease Clinical Trial
Updated: 12/31/1969
A Study of the Efficacy and Safety of Risankizumab in Subjects With Crohn's Disease Who Responded to Induction Treatment in M16-006 or M15-991; or Completed M15-989
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn's Disease Clinical Trial
Updated: 12/31/1969
A Study of the Efficacy and Safety of Risankizumab in Subjects With Crohn's Disease Who Responded to Induction Treatment in M16-006 or M15-991; or Completed M15-989
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn's Disease Clinical Trial
Updated: 12/31/1969
A Maintenance and Long-Term Extension Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Crohn's Disease Who Completed the Studies M14-431 or M14-433
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn's Disease Clinical Trial
Updated: 12/31/1969
A Maintenance and Long-Term Extension Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Crohn's Disease Who Completed the Studies M14-431 or M14-433
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn's Disease Clinical Trial
Updated: 12/31/1969
A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Biologic Therapy
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
Clinical Study Comparing PillCam® Crohn's Capsule Endoscopy to Ileocolonoscopy (IC) Plus MRE for Detection of Active CD in the Small Bowel and Colon in Subjects With Known CD and Mucosal Disease.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn's Disease Clinical Trial
Updated: 12/31/1969
Study To Evaluate The Efficacy And Safety Of Oral PF-06651600 And PF‑06700841 In Subjects With Moderate To Severe Crohn's Disease
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn's Disease Clinical Trial
Updated: 12/31/1969
Study To Evaluate The Efficacy And Safety Of Oral PF-06651600 And PF‑06700841 In Subjects With Moderate To Severe Crohn's Disease
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn's Disease Clinical Trial
Updated: 12/31/1969
Study To Evaluate The Efficacy And Safety Of Oral PF-06651600 And PF‑06700841 In Subjects With Moderate To Severe Crohn's Disease
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn's Disease Clinical Trial
Updated: 12/31/1969
A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn's Disease Clinical Trial
Updated: 12/31/1969
A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn's Disease Clinical Trial
Updated: 12/31/1969
A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn's Disease Clinical Trial
Updated: 12/31/1969
A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
